Tested Applications
| Positive WB detected in | HeLa cells, HepG2 cells, human liver tissue, Jurkat cells, human brain tissue, HEK-293 cells |
| Positive IHC detected in | human colon cancer tissue, human brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:10000 |
| Immunohistochemistry (IHC) | IHC : 1:1000-1:4000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:1000-1:4000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
66016-1-Ig targets Transketolase in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Mouse / IgG2b |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag16779 Product name: Recombinant human TKT protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 274-623 aa of BC009970 Sequence: IYSQIQSKKKILATPPQEDAPSVDIANIRMPSLPSYKVGDKIATRKAYGQALAKLGHASDRIIALDGDTKNSTFSEIFKKEHPDRFIECYIAEQNMVSIAVGCATRNRTVPFCSTFAAFFTRAFDQIRMAAISESNINLCGSHCGVSIGEDGPSQMALEDLAMFRSVPTSTVFYPSDGVATEKAVELAANTKGICFIRTSRPENAIIYNNNEDFQVGQAKVVLKSKDDQVTVIGAGVTLHEALAAAELLKKEKINIRVLDPFTIKPLDRKLILDSARATKGRILTVEDHYYEGGIGEAVSSAVVGEPGITVTHLAVNRVPRSGKPAELLKMFGIDRDAIAQAVRGLITKA Predict reactive species |
| Full Name | transketolase |
| Calculated Molecular Weight | 68 kDa |
| Observed Molecular Weight | 68 kDa |
| GenBank Accession Number | BC009970 |
| Gene Symbol | Transketolase |
| Gene ID (NCBI) | 7086 |
| RRID | AB_11064729 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | P29401 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Transketolase is a key pentose phosphate shunt enzyme that plays an important role in the production of reducing equivalents and pentose sugars. Decreased activity of transketolase has been found in patients with Alzheimer's disease and thiamine deficiency. In addition, as an important biocatalyst in stereo-specific carbon-carbon bond synthesis, transketolase has been widely used in industry to produce aromatic products.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for Transketolase antibody 66016-1-Ig | Download protocol |
| IHC protocol for Transketolase antibody 66016-1-Ig | Download protocol |
| WB protocol for Transketolase antibody 66016-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Transketolase (TKT) Monoclonal Antibody (3E2F3), catalog number 66016-1-Ig, has 2 total citations. These appear in FASEB Journal and Cancer Medicine. The cited research fields include pancreatic cancer (TKT inhibition via miRNAs potentiating chemotherapy) and colon adenocarcinoma (metabolism-related lncRNA signature for prognosis prediction). Both studies used the antibody for Western blot in human samples.
| Species | Application | Title |
|---|---|---|
FASEB J Prolactin receptor potentiates chemotherapy through miRNAs-induced G6PD/TKT inhibition in pancreatic cancer | ||
Cancer Med Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma |





















